Effectiveness of intra-articular hyaluronan (Synvisc, hylan G-F 20) for the treatment of first metatarsophalangeal joint osteoarthritis: A randomised placebo-controlled trial

Annals of the Rheumatic Diseases

Volumn 70, Issue 10, 2011, Pages 1838-1841

  Munteanu, Shannon E ^a   Zammit, Gerard V ^a   Menz, Hylton B ^a   Landorf, Karl B ^a   Handley, Christopher J ^a   Elzarka, Ayman ^a   DeLuca, Jason ^a  

^a LA TROBE UNIVERSITY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

HYALURONIC ACID; PLACEBO;

ADULT; ARTHRALGIA; ARTICLE; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG WITHDRAWAL; FEMALE; FIRST METATARSOPHALANGEAL JOINT DORSIFLEXION; FIRST METATARSOPHALANGEAL JOINT OSTEOARTHRITIS; FOLLOW UP; FOOT DISEASE; FOOT HEALTH STATUS QUESTIONNAIRE; FOOT PAIN; HALLUX; HUMAN; INJECTION SITE CELLULITIS; JOINT STIFFNESS; MAJOR CLINICAL STUDY; MALE; METATARSOPHALANGEAL JOINT; MUSCLE STRENGTH; MUSCULOSKELETAL SYSTEM PARAMETERS; OSTEOARTHRITIS; PATIENT SATISFACTION; PLANTAR PRESSURE DURING BAREFOOT WALKING; PRIORITY JOURNAL; QUALITY OF LIFE; QUESTIONNAIRE; RANDOMIZED CONTROLLED TRIAL; RANGE OF MOTION; SHORT FORM 36;

ADULT; DOUBLE-BLIND METHOD; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYALURONIC ACID; INJECTIONS, INTRA-ARTICULAR; MALE; METATARSOPHALANGEAL JOINT; MIDDLE AGED; OSTEOARTHRITIS; PAIN; RANGE OF MOTION, ARTICULAR; TREATMENT OUTCOME; VISCOSUPPLEMENTATION; VISCOSUPPLEMENTS;

EID: 80052470216     PISSN: 00034967     EISSN: 14682060     Source Type: Journal    
DOI: 10.1136/ard.2011.153049     Document Type: Article

References (20)

1. Van Saase J.L., Van Romunde L.K., Cats A., et al. Epidemiology of osteoarthritis: Zoetermeer survey. Comparison of radiological osteoarthritis in a Dutch population with that in 10 other populations. Ann Rheum Dis 1989;48:271-280 (Pubitemid 19107329)
2. Coughlin M.J., Shurnas PS. Hallux rigidus: Demographics, etiology, and radiographic assessment. Foot Ankle Int 2003;24:731-743 (Pubitemid 37248428)
3. Camasta C.A. Hallux limitus and hallux rigidus. Clinical examination, radiographic findings, and natural history. Clin Podiatr Med Surg 1996;13:423-448 (Pubitemid 26274239)
4. Abhishek A., Roddy E., Zhang W., et al. Are hallux valgus and big toe pain associated with impaired quality of life? A cross-sectional study. Osteoarthr Cartil 2010;18:923-926
5. Zammit G V, Menz HB, Munteanu SE, e t al. Interventions for treating osteoarthritis of the big toe joint. Cochrane Database Syst Rev 2010;9:CD007809.
6. Balazs E.A., Denlinger JL. Viscosupplementation: A new concept in the treatment of osteoarthritis. J Rheumatol Suppl 1993;39:3-9. (Pubitemid 23284286)
7. Bellamy N., Campbell J., Robinson V., et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev 2006;19:CD005321.
8. Campbell J., Bellamy N, Gee T. Differences between systematic reviews/metaanalyses of hyaluronic acid/hyaluronan/hylan in osteoarthritis of the knee. Osteoarthr Cartil 2007;15:1424-1436 (Pubitemid 350048556)
9. Pons M., Alvarez F, Solana J, e t al. Sodium hyaluronate in the treatment of hallux rigidus. A single-blind, randomized study. Foot Ankle Int 2007;28:38-42. (Pubitemid 46106332)
10. Maher A. An audit of the use of sodium hyaluronate 1% (Ostenil® Mini) therapy for the treatment of hallux rigidus . Br J Podiatry 2007;10:47-51.
11. Petrella R.J., Cogliano A. Intra-articular Hyaluronic Acid Treatment for Golfer's Toe: Keeping Older Golfers on Course. Phys Sportsmed 2004;32:41-45 (Pubitemid 38900404)
12. Schulz K F, Chalmers I, Hayes RJ, e t al. Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials. JAMA 1995;273:408-412
13. Munteanu S E, Menz HB, Zammit GV, e t al. Efficacy of intra-articular hyaluronan (Synvisc®) for the treatment of osteoarthritis affecting the first metatarsophalangeal joint of the foot (hallux limitus): Study protocol for a randomised placebo controlled trial. J Foot Ankle Res 2009;2:2.
14. Bennett P J, Patterson C, Wearing S, e t al. Development and validation of a questionnaire designed to measure foot-health status. J Am Podiatr Med Assoc 1998;88:419-428 (Pubitemid 128686938)
15. Gibaldi M., Sullivan S. Intention-to-treat analysis in randomized trials: Who gets counted? J Clin Pharmacol 1997;37:667-672 (Pubitemid 27449275)
16. Peat J.K., Barton B. Medical Statistics: A Guide to Data Analysis and Critical Appraisal . Malden, MA:Blackwell 2005.
17. Twisk J., Proper K. Evaluation of the results of a randomized controlled trial: How to define changes between baseline and follow-up. J Clin Epidemiol 2004;57:223-228 (Pubitemid 38456873)
18. Lo G H, LaValley M, McAlindon T, e t al. Intra-articular hyaluronic acid in treatment of knee osteoarthritis: A meta-analysis. JAMA 2003;290:3115-3121 (Pubitemid 37548117)
19. Zhang W., Nuki G, Moskowitz RW, e t al. OARSI recommendations for the management of hip and knee osteoarthritis: Part III: Changes in evidence following systematic cumulative update of research published through January 2009. Osteoarthr Cartil 2010;18:476-499
20. Menz H B, Munteanu S.E., Landorf K.B., et al. Radiographic classification of osteoarthritis in commonly affected joints of the foot. Osteoarthr Cartil 2007;15:1333-1338 (Pubitemid 350029047)